Total
USD $0.00
 
 
Mexico

Genomma Lab Internacional, S.A.B. DE C.V.

An EMIS Company Report EMIS is a Euromoney Institutional Investor plc company USD 29.95 Industry: Pharmaceutical and Medicine Manufacturing Available in: English & Spanish Format: PDF Download Most recent financial data: 2016 Buy full report

What’s included?

This report extracts all available information about Genomma Lab Internacional, S.A.B. DE C.V. from EMIS' database of company information. The Table of Contents on the right indicates the categories of information that will be included in your report upon purchase.

Download a sample report

Company Tear Sheet (locked content will be provided in the purchased report)

Contact Information

Headquarters
Antonio Dovali Jaime No. 70 Piso 2 Torre B Santa Fe
Mexico City; Federal District of Mexico City; Map
Postal Code: 01210

Tel: +52-55-5081-

Email:
@genommalab.com

Website:
http://www.genommalab.com

Company Description
Genomma Lab S.A.B. de C.V. is a pharmaceutical research company, manufacturer and seller of pharmaceutical and cosmetic products. It has strong presence not only in Mexico but also exports its products to more than 30 countries. It has offices in Spain, Argentina, Peru and China. Genomma Lab was established in 1996 as a publicity company for direct consumers with the capacity of producing infomercials for TV. In 2004 a private investment fund operated by "Nexxus Capital", which is a Mexican private investments funds manager, acquired 30% of the shares of Genomma Lab.
NAICS Industry Classification
Main Activities: Pharmaceutical and Medicine Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences
Basic Information
Total Employees:
1,380 (2012)
Outstanding Shares:
: ()
Financial Auditors:
()
Incorporation Date:
October 30, 1996
Profile Updated:
January 09, 2018
Key Executives
Chairman of the Board of Directors
Member of Board of Directors
Member of Board of Directors
Vice President
Chief Executive Officer
Ownership Details
Rodrigo Alonso Herrera Aspa
26.1%
Other
Key Financial Highlights
2017 Q3C
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss) for the Period
Total assets 15,867,312
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Consolidated
Source: Bolsa Mexicana de Valores, EMIS Company Database.
Financial Performance Charts
Top Competitors

Financial Statements

Annual Statements

EMIS Credit Analytics

EMIS Benchmark Score
Enterprise ACCESS

If you need regular and ongoing access to company information, you should consider a subscription to the full EMIS service.

EMIS company profiles are part of a larger information service where that combines company, industry and country data and analysis for over 125 emerging markets on a unique information platform.

REQUEST A DEMO

To view more information, REQUEST A DEMO